Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency

Radiotherapy and Oncology

Volumn 64, Issue 3, 2002, Pages 297-308

  Nag, Subir ^a   Dally, Michael ^b   De La Torre, Marcela ^c   Tatsuzaki, Hideo ^d   Kizilbash, Nori ^e   Kurusun, Srichai ^f   Pinillos, Luis ^g   Pokrajac, Boris ^h   Sur, Ranjan ⁱ   Levin, Victor ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^e PAKISTAN ATOMIC ENERGY COMMISSION   (Pakistan)

^f KHON KAEN UNIVERSITY   (Thailand)

^g INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^h Clinic for Radiotherapy and Radiobiology   (Austria)

ⁱ JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Brachytherapy; Developing countries; High dose rate; Iridium 192

Indexed keywords

IRIDIUM 192;

ARTICLE; BIOSAFETY; BUDGET; DEVELOPING COUNTRY; HEALTH CARE POLICY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RADIATION APPLICATOR; RADIATION DOSE; RADIATION EQUIPMENT; RADIATION RESPONSE; RADIOISOTOPE THERAPY; TREATMENT PLANNING;

BRACHYTHERAPY; COBALT RADIOISOTOPES; COSTS AND COST ANALYSIS; DEVELOPING COUNTRIES; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH PLAN IMPLEMENTATION; HUMANS; INTERNATIONAL AGENCIES; IRIDIUM RADIOISOTOPES; LUNG NEOPLASMS; MALE; NUCLEAR ENERGY; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS;

EID: 0036711319     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00166-4     Document Type: Article

References (47)

1. Abitbol A., Nag S., Lewin A., et al. High dose rate brachytherapy. Leibel S.A., Phillips T.L., Textbook of radiation oncology. 1998;232-252 WB Saunders, Philadelphia, PA.
2. Akine Y., Tokita N., Ogino T., et al. Dose equivalence for high-dose rate to low-dose rate intracavitary irradiation in the treatment of cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 19:1990;1511-1514.
3. American Association of Physicists in Medicine . Remote afterloading technology, AAPM Report No. 41. 1993;American Institute of Physics, New York, NY.
4. Arai T., Nakano T., Morita S., et al. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. Cancer. 69:1992;175-180.
5. Bastin K., Buchler D., Still J., et al. Resource utilization. High dose rate versus low dose rate brachytherapy for gynecological cancer. Am J Clin Oncol. 16:(3):1993;256-263.
6. Flores A.D., Rowland C.G., Yin W.-B. High dose rate brachytherapy of carcinoma of the esophagus. Nag S., High dose rate brachytherapy: a textbook. 1994;275-294 Futura Publishing, Armonk, NY.
7. Fu K.K., Phillips T.L. High-dose rate vs low-dose rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 19:1990;791-796.
8. Gaspar L.E., Nag S., Herskovic A., et al. American Brachytherapy Society (ABS) Consensus Guidelines for Brachytherapy of Esophageal Cancer. Int J Radiat Oncol Biol Phys. 38:1997;127-132.
9. Henschke U.K., Hilaris B.S., Mahan G.D. Remote afterloading with intracavitary applicators. Radiology. 83:1964;344-345.
10. Hishikawa Y., Kurisu K., Taniguchi M., et al. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol. 21:1991;107-114.
11. International Commission on Radiation Units and Measurements. Dose and Volume Specification for reporting intracavitary therapy in gynecology, ICRU report 38. Bethesda, USA, 1985.
12. International Commission on Radiation Units and Measurements. Dose and Volume Specification for reporting interstitial therapy. ICRU report 58. Bethesda, MD, USA, 1997.
13. International Electrotechnical Commission. Medical Electrical Equipment. Part 2: Particular Requirements for the Safety of Remote-Controlled Automatically-Driven Gamma-Ray Afterloading Equipment, Publ. IEC, Geneva, General, 1989.
14. International Atomic Energy Agency. Design and Implementation of a Radiotherapy Programme: Clinical, Medical Physics, Radiation Protection and Safety Aspects, IAEA-TECDOC-1040, Vienna, 1998.
15. John T.J., Balraj V., John R. Disease surveillance at district level: a model for developing countries. Lancet. 352:1998;58-61.
16. Jones G., Lukka H., O'Brien B. High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysis. Br J Radiol. 67:(803):1994;1113-1120.
17. Kubo H.D., Glasgow G.P., Pethel T.D., et al. American Association Of Physicist In Medicine . High dose rate brachytherapy treatment dose delivery: report of AAPM Radiation Therapy Committee Task Group No. 59. Med Phys. 25:1998;375-403.
18. Kutcher G.J., Coia L., Gillen M., et al. American Association Of Physicist In Medicine . Comprehensive QA for Radiation Oncology: Report of AAPM Radiation Therapy Committee Task Group-40. Med Phys. 21:1994;581-618.
19. Levendag P.C., Vikram B., Flores A.D., et al. High dose rate brachytherapy for cancer of the head and neck. Nag S., High dose rate brachytherapy: a textbook. 1994;237-273 Futura Publishing, Armonk, NY.
20. Marcario A., Vitez T.S., Dunn B., McDonald T. What are the costs in peri-operative care? Analysis of hospital costs and charges for inpatient surgical care. Anesthesiology. 83:(6):1995;1138-1144.
21. Nag S. Clinical aspects of HDR brachytherapy. Perez C., Principles and practice of radiation oncology. 4th ed. 2002;Lippincott-Raven, Philadelphia, PA. (in press).
22. Nag S., High dose rate brachytherapy: a textbook. 1994;Futura Publishing, Armonk, NY.
23. Nag S., Principles and practice of brachytherapy. 1997;Futura Publishing, Armonk, NY.
24. Nag S., Chao C., Erickson B., et al. The American Brachytherapy Society Recommendations for LDR Brachytherapy of the Cervix. Int J Radiat Oncol Biol Phys. 52:2002;33-48.
25. Nag S., Kelly J.F., Horton J.L., et al. The American Brachytherapy Society Recommendations for HDR Brachytherapy for Carcinoma of the Lung. Oncology. 15:2001;371-381.
26. Nag S., Martinez-Monge R., Gupta N. Intraoperative radiation therapy using electron-beam and high-dose-rate brachytherapy. Cancer J. 10:1997;94-101.
27. Nag S., Orton C., Petereit D., et al. The American Brachytherapy Society Recommendations for HDR Brachytherapy of the Cervix. Int J Radiat Oncol Biol Phys. 48:2000;201-211.
28. Nag S., Orton C., Young D., Erickson B. American Brachytherapy Society Survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol. 73:1999;111-118.
29. Nag S., Samsami N. Pitfalls of inappropriate optimization. J Brachyther Int. 16:2000;187-198.
30. Nag S., Vikram B., Demanes J.D., et al. The American Brachytherapy Society Recommendations for HDR Brachytherapy for Head and Neck Carcinoma. Int J Radiat Oncol Biol Phys. 50:2001;1190-1198.
31. National Committee on Radiation Protection and Measurements. Structural Shielding Design and Evaluation for Medical Use of X-Rays and Gamma Rays of Energies up to 10 MeV, NCRP 49, NCRP, Washington, DC, 1976.
32. Nundy S. Difficulties of surgery in the developing world: a personal view. Lancet. 353:(Suppl 1):1999;21-23.
33. O'connell D., Howard N., Joslin C.A., et al. A remotely-controlled unit for the treatment of uterine carcinoma. Lancet. 2:1965;570.
34. Orton C.G. High and low dose rate brachytherapy for cervical cancer. Acta Oncol. 37:1998;117-125.
35. Orton C.G., Seyedsadr M., Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 21:1991;1425-1434.
36. Patel F.D., Sharma S.C., Negi P.S., et al. Low dose rate vs HDR brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys. 28:1994;335-341.
37. Petereit D.G., Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 43:1999;359-366.
38. Pinilla J. Cost minimization analysis of high dose rate versus low dose rate brachytherapy in endometrial cancer. Gynecology Tumor Group. Int J Radiat Oncol Biol Phys. 42:(1):1998;87-90.
39. Roth J.A., Lichter A.S., Putnam J.B., Forastiere A.A. Cancer of the esophagus. DeVita V.T., Hellman S., Rosenberg S.A., Principles and practice of oncology. 4th ed. 1993;776-817.
40. Shigematsu Y., Nishiyama K., Masaki N., et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with HDR: a comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys. 9:1983;351-356.
41. Sievert R.M. Two arrangements for reducing dangers in teleradium treatment. Acta Radiol. 18:1937;157-162.
42. Sur R.J., Donde B., Levin C.V., et al. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 40:(2):1998;447-453.
43. Teshima T., Inoue T., Ikeda H., et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Cancer. 72:1993;2409-2414.
44. Van den Broek G., Weatherburn H. Re-evaluation of a radiation protection cost benefit analysis study in brachytherapy. Br J Radiol. 67:1994;59-62.
45. Van't Hooft E. The selectron. Shearer D.R., Recent advances in brachytherapy physics, PM Monograph No. 7. 1981;167-177 American Institute of Physics, New York, NY.
46. Wakabayashi M., Ohsawa T., Mitsuhashi H., et al. High dose rate intracavitary radiotherapy using the RALSTRON. Introduction and Part I. (Treatment of carcinoma of the uterine cervix). Nippon Acta Radiol. 31:1971;340-378.
47. Walstam R. Studies on therapeutic short-distance and intracavitary gamma beam techniques. Acta Radiol Suppl. 236:1965;1-129.